Botulism pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:
==Images==
==Images==


[[Image:Botulism outbreak.jpg|400px|This is a close up of contaminated Jalapeño peppers involved in an outbreak of botulism in Pontiac, Michigan, April, 1977. Ingestion of botulinal toxin results in an illness of variable severity. Common symptoms are diplopia, blurred vision, and bulbar weakness. Symmetric paralysis may progress rapidly.]]
<gallery>
 
Image:Botulism outbreak.jpg|This is a close up of contaminated Jalapeño peppers involved in an outbreak of botulism in Pontiac, Michigan, April, 1977. Ingestion of botulinal toxin results in an illness of variable severity. Common symptoms are diplopia, blurred vision, and bulbar weakness. Symmetric paralysis may progress rapidly.
[[Image:Botulism type E.jpg|400px|These are Clostridium botulinum Type E colonies displaying an opaque zone grown on a 48hr egg yolk agar plate; Mag. 1.9
Image:Botulism type E.jpg|These are Clostridium botulinum Type E colonies displaying an opaque zone grown on a 48hr egg yolk agar plate; Mag. 1.9 C. botulinum Type E is an indigenous organism in the aquatic environment, and is the type mainly associated with botulism from seafood products. It is a Gram-positive, anaerobic, -forming food borne pathogen.
 
Image:Botulism type A.jpg|This Gram-stained micrograph of Clostridium botulinum Type-A in thioglycollate broth was incubated for 48hrs at 35°C. C. botulinum is the bacterium responsible for the condition known as botulism, producing a neurotoxin the effects of which may be neutralized by various therapeutic agents.
C. botulinum Type E is an indigenous organism in the aquatic environment, and is the type mainly associated with botulism from seafood products. It is a Gram-positive, anaerobic, spore-forming food borne pathogen.]]
Image:Botulism 2 type A.jpg|This is a Clostridium botulinum type A colony grown on a 72 hour blood agar plate; Magnification 5X. The bacterium C. botulinum produces a nerve toxin, which causes the rare, but serious paralytic illness Botulism. There are seven types of botulism toxin designated by the letters A through G; only types A, B, E and F cause illness in humans.
 
Image:Botulism 3 type A.jpg|These are Clostridium botulinum Type A colonies, Strain 2, grown on a 48hr blood agar plate.  The bacterium C. botulinum produces a nerve toxin, which causes the rare, but serious paralytic illness Botulism. There are seven types of botulism toxin designated by the letters A through G; only types A, B, E and F cause illness in humans.
[[Image:Botulism type A.jpg|400px|This Gram-stained micrograph of Clostridium botulinum Type-A in thioglycollate broth was incubated for 48hrs at 35°C
Image:Botulism wound.jpg|Wound botulism involvement of compound fracture of right arm.  14-year-old boy fractured his right ulna and radius and subsequently developed wound botulism.
 
Image:Botulism infant.jpg|Six week old infant with botulism. Six week old infant with botulism, which is evident as a marked loss of muscle tone, especially in the region of the head and neck.
C. botulinum is the bacterium responsible for the condition known as botulism, producing a neurotoxin the effects of which may be neutralized by various therapeutic agents.]]
Image:Botulism spores.jpg|Clostridium botulinum spores stained with Malachite Green Stain.  The endospores of C. botulinum when stained using the Malachite Green staining method will appear as green spheres, while the bacilli themselves will turn purple in color.
 
</gallery>
[[Image:Botulism 2 type A.jpg|400px|This is a Clostridium botulinum type A colony grown on a 72 hour blood agar plate; Magnification 5X. The bacterium C. botulinum produces a nerve toxin, which causes the rare, but serious paralytic illness Botulism. There are seven types of botulism toxin designated by the letters A through G; only types A, B, E and F cause illness in humans.]]
 
[[Image:Botulism 3 type A.jpg|400px|These are Clostridium botulinum Type A colonies, Strain 2, grown on a 48hr blood agar plate.  The bacterium C. botulinum produces a nerve toxin, which causes the rare, but serious paralytic illness Botulism. There are seven types of botulism toxin designated by the letters A through G; only types A, B, E and F cause illness in humans.]]
 
[[Image:Botulism wound.jpg|400px|Wound botulism involvement of compound fracture of right arm.  14-year-old boy fractured his right ulna and radius and subsequently developed wound botulism.]]
 
[[Image:Botulism infant.jpg|400px|Six week old infant with botulism. Six week old infant with botulism, which is evident as a marked loss of muscle tone, especially in the region of the head and neck.]]
 
[[Image:Botulism spores.jpg|400px|Clostridium botulinum spores stained with Malachite Green Stain.  The endospores of C. botulinum when stained using the Malachite Green staining method will appear as green spheres, while the bacilli themselves will turn purple in color.]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 19:53, 16 February 2012

Botulism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Botulism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Botulism pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Botulism pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Botulism pathophysiology

CDC on Botulism pathophysiology

Botulism pathophysiology in the news

Blogs on Botulism pathophysiology

Directions to Hospitals Treating Botulism

Risk calculators and risk factors for Botulism pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

Microbiology

Clostridium botulinum is an obligate anaerobe that forms spores. The natural habitat for the Clostridium botulinum spores is the soil. The species of Clostridium botulinum is made up of 4 genetically diverse groups that do not have much in common other than the fact that they all produce the botulinum toxin[1]. The botulinum toxin itself exists as 7 different antigenic types and these 7 antigenic types have been assigned a series of letters: A, B, C, D, E, F, G[1]. These toxins have a specific definition, and they are defined by their inability to cross neutralize the other types. For example, Anti-A toxin can not neutralize any of the other toxin types (B-G). It should be noted that Clostridium baratii and Clostridium butyricum can also produce the botulinum toxin[1].

The botulinum molecule itself is composed of a heavy chain as well as a light chain polypeptide. It is referred to as a dichain polypeptide. The light chain of the toxin contains an endopeptidase that blocks acetylcholine-containing vesicles from being able to fuse with the membrane at the end of the motor neuron. If acetycholine is not present, it will result in flaccid muscle paralysis[1].

Many people may not realize it, but the commercial therapeutic procedure termed "Botox" actually contains the botulinum toxin. However, there is a very small amount of it present, otherwise it would present an extensive danger. A vial of type A preparation, which is currently licensed in the US, contains only about 0.005% of the lethal oral dose and 0.3% of the lethal inhalation dose[1].

Images

References

  1. 1.0 1.1 1.2 1.3 1.4 Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K (2001). "Botulinum toxin as a biological weapon: medical and public health management". JAMA : the Journal of the American Medical Association. 285 (8): 1059–70. PMID 11209178. Retrieved 2012-02-16. Unknown parameter |month= ignored (help)